Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001842952-25-000055
Filing Date
2025-06-09
Accepted
2025-06-09 17:13:50
Documents
2
Period of Report
2025-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1749503581.html 3  
1 FORM 3 wk-form3_1749503581.xml 3 1698
2 EX-24 context-karendeborahchagin.htm EX-24 15331
  Complete submission text file 0001842952-25-000055.txt   18625
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Issuer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2001 MARKET STREET SUITE 3915, UNIT 15 PHILADELPHIA PA 19103
Business Address
Chagin Karen Deborah (Reporting) CIK: 0002070710 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40654 | Film No.: 251035044